Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma.
Oncoimmunology. 2022 May 31;11(1):2081415. doi: 10.1080/2162402X.2022.2081415. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35694192
Free PMC article.
Nonviral technologies can pave the way for CAR-NK cell therapy.
Bexte T, Reindl LM, Ullrich E.
Bexte T, et al. Among authors: reindl lm.
J Leukoc Biol. 2023 Oct 26;114(5):475-486. doi: 10.1093/jleuko/qiad074.
J Leukoc Biol. 2023.
PMID: 37403203
Review.
Item in Clipboard
Unleashing the power of NK cells in anticancer immunotherapy.
Vogler M, Shanmugalingam S, Särchen V, Reindl LM, Grèze V, Buchinger L, Kühn M, Ullrich E.
Vogler M, et al. Among authors: reindl lm.
J Mol Med (Berl). 2022 Mar;100(3):337-349. doi: 10.1007/s00109-021-02120-z. Epub 2021 Aug 9.
J Mol Med (Berl). 2022.
PMID: 34374809
Free PMC article.
Review.
Item in Clipboard
Immunotherapy with NK cells: recent developments in gene modification open up new avenues.
Reindl LM, Albinger N, Bexte T, Müller S, Hartmann J, Ullrich E.
Reindl LM, et al.
Oncoimmunology. 2020 Sep 2;9(1):1777651. doi: 10.1080/2162402X.2020.1777651.
Oncoimmunology. 2020.
PMID: 33457093
Free PMC article.
Review.
Item in Clipboard
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy.
Wendel P, Reindl LM, Bexte T, Künnemeyer L, Särchen V, Albinger N, Mackensen A, Rettinger E, Bopp T, Ullrich E.
Wendel P, et al. Among authors: reindl lm.
Cancers (Basel). 2021 Mar 23;13(6):1481. doi: 10.3390/cancers13061481.
Cancers (Basel). 2021.
PMID: 33807011
Free PMC article.
Review.
Item in Clipboard
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.
Särchen V, Reindl LM, Wiedemann S, Shanmugalingam S, Bukur T, Becker J, Suchan M, Ullrich E, Vogler M.
Särchen V, et al. Among authors: reindl lm.
Cells. 2023 Mar 15;12(6):906. doi: 10.3390/cells12060906.
Cells. 2023.
PMID: 36980247
Free PMC article.
Item in Clipboard
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy.
Särchen V, Shanmugalingam S, Kehr S, Reindl LM, Greze V, Wiedemann S, Boedicker C, Jacob M, Bankov K, Becker N, Wehner S, Theilen TM, Gretser S, Gradhand E, Kummerow C, Ullrich E, Vogler M.
Särchen V, et al. Among authors: reindl lm.
Cell Death Discov. 2022 Jan 10;8(1):11. doi: 10.1038/s41420-021-00812-6.
Cell Death Discov. 2022.
PMID: 35013156
Free PMC article.
Item in Clipboard
Cite
Cite